Share on facebook
Share on twitter
Share on linkedin
Share on telegram
Share on whatsapp

Germany offers booster shots 4 weeks after last vaccination as Study finds COVID-19 Vaccines Induce Lower Antibodies Against Omicron Variant

Share on facebook
Share on twitter
Share on telegram
Share on email
Share on print


Redaktionsnetzwerk Deutschland
Booster vaccinations in NRW are now possible after four weeks

  • Booster vaccinations are possible earlier in North Rhine-Westphalia as the first federal state.
  • Citizens can get a booster vaccination after just four weeks.
  • The reason for this is that many people have recently been turned away because the second vaccination was less than five months ago.

In North Rhine-Westphalia, the booster vaccinations are now possible much earlier. Citizens can get the booster just four weeks after the second vaccination, reports the “Siegener Zeitung”, a partner of the RedaktionsNetzwerk Deutschland (RND) . Previously, this period was five months.

A corresponding decree had gone to all circles, a spokeswoman for the health ministry confirmed to the newspaper. The aim of the decree is that nobody is sent away from the vaccination center just because less than five months have passed since the second vaccination…Read More

Vaccines induce lower levels of neutralising antibodies against omicron, boosters improve levels: study

Medical Xpress – Researchers from the University of Oxford have analyzed the impact of the omicron COVID-19 variant of concern on one of the immune responses generated by vaccination.

Using blood samples from individuals who had previously received two doses of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines as part of the Com-COV study, and a live virus isolate, they demonstrate substantial decrease in neutralizing titres—a measure of the level of neutralizing antibodies generated in responses to vaccination against, or infection from, COVID-19.

The results, published on the pre-print server MedRxiv, indicate that the omicron variant has the potential to drive a further wave of infections, including among those already vaccinated, although the researchers highlight that there is currently no evidence of increased potential to cause severe disease, hospitalisations or deaths in vaccinated populations.

These results align with recently published data from UK Health Security Agency, showing reduced effectiveness of two doses of these vaccines against symptomatic disease due to the omicron variant compared to delta. Importantly, this effectiveness was improved by a third dose of vaccine. Read more

Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x

Get in Touch!

Purpose of your Contact
Where can i reach you?
What would you like to discuss?

Are you intending to visit the Lorphic marketing agency?